| HOME >> BIOLOGY >> TECHNOLOGY |
US market for fixed C-arms to grow over 5% annually over the next five
years, according to Millennium Research Group
WALTHAM, Mass., Feb. 21 /PRNewswire/ -- According to Millennium Research Group's Global Markets for C-Arms 2008 report, the US market for fixed C-arm systems, comprising units used for cardiology, angiography, and neuroradiology procedures, was valued at over $1.4 billion in 2007 and will rise to over $1.8 billion by 2012.
In the US, several hospitals have begun using fixed C-arms in operating room (OR) environments. This trend has emerged as a result of the physician movement towards collaborative surgeries, in which many specialists work together to perform complex procedures. The installation of a C-arm system in the OR allows for the ideal imaging environment for this approach.
"A fixed C-arm offers the advanced imaging capabilities required to treat many complex procedures," says Ryan Goren, Analyst at Millennium Research Group. "These systems provide surgeons with the best imaging experience possible when performing complex interventional procedures, such as interventional cardiology and interventional radiology."
The Global Markets for C-Arms report includes coverage of US, Europe (France, Germany, Italy, and the UK), and Asia Pacific (Japan, China, India, Singapore, South Korea, and Taiwan). The report provides coverage of all key industry competitors, including GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba Healthcare, and Shimadzu.
About C-Arms
Fixed C-arms are X-ray systems used in complex angiography, cardiology,
and neuroradiology procedures. Single-plane systems consist of a single
C-arm, while biplane systems comprise two C-arms mounted at a 90-degree
angle in relation to each other. Fixed C-arm systems are used to guide
surgeons performing interventional procedures. Modern flat-panel detector
systems provide surgeons with superior image quality when perfor
'/>"/>
| SOURCE Millennium Research Group Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
2. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
3. 3-D photonic crystals will revolutionize telecommunications
4. Siemens New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow
5. Nanotechnology innovation may revolutionize gene detection in a single cell
6. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
8. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
9. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
10. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
11. Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |